Cogent Biosciences (COGT) Enterprise Value
Price: $4.30
Market Cap: $489.56M
Avg Volume: 1.42M
Market Cap: $489.56M
Avg Volume: 1.42M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Cogent Biosciences's latest quarterly financial reports:
- The enterprise value (EV) is 780.90M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 572.13M, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $7.8, with 110.46M shares outstanding.
- The company has 98.17M in cash and cash equivalents and 17.47M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$780.90M
Market Cap
$861.60M
Total Debt
$17.47M
Cash and Equivalents
$98.17M
Historical Enterprise Value
Cogent Biosciences Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $780.90M | -29.68% | $7.8 | 110.46M | $861.60M | $98.17M | $17.47M |
| September 30, 2024 | $1.11B | 35.90% | $10.8 | 110.17M | $1.19B | $97.05M | $17.83M |
| June 30, 2024 | $817.17M | 78.86% | $8.94 | 99.24M | $887.21M | $88.22M | $18.18M |
| March 31, 2024 | $456.87M | -3.94% | $6.9 | 94.80M | $654.15M | $215.80M | $18.52M |
| December 31, 2023 | $475.60M | -38.43% | $5.88 | 86.73M | $509.97M | $53.23M | $18.85M |
| September 30, 2023 | $772.48M | 11.93% | $9.75 | 86.17M | $840.12M | $86.81M | $19.17M |
| June 30, 2023 | $690.12M | 10.95% | $11.84 | 74.75M | $885.08M | $214.32M | $19.36M |
| March 31, 2023 | $621.99M | -10.46% | $10.79 | 70.73M | $763.23M | $160.70M | $19.46M |
| December 31, 2022 | $694.62M | -24.30% | $11.56 | 70.49M | $814.86M | $139.89M | $19.65M |
| September 30, 2022 | $917.59M | 520.03% | $14.92 | 69.58M | $1.04B | $140.57M | $20.08M |
| June 30, 2022 | $147.99M | -1.55% | $9.02 | 49.39M | $445.49M | $325.56M | $28.07M |
| March 31, 2022 | $150.32M | -5.65% | $7.49 | 45.11M | $337.84M | $191.05M | $3.52M |
| December 31, 2021 | $159.33M | 17.21% | $8.58 | 43.81M | $375.85M | $219.68M | $3.15M |
| September 30, 2021 | $135.93M | 38.89% | $8.41 | 39.85M | $335.13M | $202.89M | $3.69M |
| June 30, 2021 | $97.87M | 22.00% | $8.11 | 38.44M | $311.76M | $218.10M | $4.21M |
| March 31, 2021 | $80.22M | -454.65% | $8.78 | 34.88M | $306.24M | $230.74M | $4.72M |
| December 31, 2020 | $-22.62M | -28.28% | $11.23 | 19.09M | $214.36M | $242.19M | $5.21M |
| September 30, 2020 | $-31.54M | 1663.57% | $9.36 | 9.85M | $92.20M | $129.42M | $5.68M |
| June 30, 2020 | $-1.79M | -84.49% | $1.84 | 7.78M | $14.31M | $21.34M | $5.24M |
| March 31, 2020 | $-11.53M | 23.76% | $1.65 | 7.53M | $12.43M | $29.60M | $5.64M |
| December 31, 2019 | $-9.31M | -298.94% | $2.88 | 7.67M | $22.08M | $37.42M | $6.03M |
| September 30, 2019 | $4.68M | -80.84% | $5.76 | 7.67M | $44.15M | $45.88M | $6.41M |
| June 30, 2019 | $24.44M | -69.60% | $9.64 | 7.63M | $73.52M | $55.86M | $6.79M |
| March 31, 2019 | $80.40M | 6.07% | $17.6 | 7.52M | $132.37M | $59.11M | $7.15M |
| December 31, 2018 | $75.80M | -70.91% | $17.6 | 7.47M | $131.47M | $55.67M | $- |
| September 30, 2018 | $260.55M | -29.89% | $41.48 | 7.47M | $309.85M | $49.30M | $- |
| June 30, 2018 | $371.65M | 323.93% | $57.4 | 7.29M | $418.39M | $46.73M | $- |
| March 31, 2018 | $87.67M | -62.20% | $44.44 | 2.55M | $113.37M | $25.70M | $- |
| December 31, 2017 | $231.94M | 1.06% | $44.44 | 5.86M | $260.21M | $28.27M | $- |
| September 30, 2017 | $229.51M | -11.80% | $44.44 | 5.86M | $260.21M | $30.70M | $- |
| June 30, 2017 | $260.21M | 0.00% | $44.44 | 5.86M | $260.21M | $- | $- |
| March 31, 2017 | $260.21M | -56.79% | $44.44 | 5.86M | $260.21M | $- | $- |
| September 30, 2016 | $602.24M | 260.61% | $44.44 | 12.66M | $562.74M | $10.39M | $49.90M |
| September 30, 2015 | $167.01M | - | $44.44 | 3.76M | $167.01M | $- | $- |
Related Metrics
Explore detailed financial metrics and analysis for COGT.